T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: Analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1669-1679

  Kalams, Spyros A ^a   Johnson, R Paul ^a,b   Dynan, Mark J ^a   Hartman, Kelly E ^a   Harrer, Thomas ^a   Harrer, Ellen ^a   Trocha, Alicja K ^a   Blattner, William A ^c   Buchbinder, Susan P ^d   Walker, Bruce D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d AIDS Office San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA ANTIGEN CLASS 1; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HLA TYPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE CLONE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BASE SEQUENCE; CLONE CELLS; HISTOCOMPATIBILITY TESTING; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; VARIATION (GENETICS);

EID: 0029935149     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1669     Document Type: Article

References (34)

1. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
2. Klein, M.R., C.A. van Baalen, A.M. Holwerda, S.R. Kerkhof Garde, R.J. Bende, I.P. Keet, J.K. Eeftinck-Schattenkerk, A.D. Ostcrhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp Med. 181:1365-1372.
3. Harrer, T., E. Harrer, S.A Kalanis, T. Elbeik, M. Feinberg, Y. Cao, D.D. Ho, T. Yilma, A.M. Caliendo, R.P. Johnson, S.P. Buchbinder, and B.D. Walker. 1996. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV-1 infection. AIDS Res. Hum. Retro In press.
4. Moss, P.A., R.J. Moots, W.M. Rosenberg, S.J. Rowland-Jones, H.C. Bodmer, A.J. McMichael, and J.I. Bell. 1991 Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA. 88:8987-8990.
5. Lehner, P.J., E.G. Wang, P.A. Moss, S. Williams, K. Platt, S.M. Friedman, J.I. Bell, and L.K. Borysicwicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V β 17 gene segment. J. Exp. Med. 181:79-91.
6. Bowness, P., P.A. Moss, S. Rowland-Jones, J.I. Bell, and A.J. McMichael. 1993. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses. Eur. J. Immunol. 23:1417-1421.
7. Kalams, S.A., R.P. Johnson, A.K. Trocha, M.J. Dynan, H.S. Ngo, R.T. D'Aquila, J.T. Kurnick, and B.D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
8. Argaet, V.P., C.W. Schmidt, S.R. Burrows, S.L. Silins, M.G. Kurilla, D.L. Doolan, A. Suhrbier, D.J. Moss, E. Kieff, T.B. Suclley et al., 1994. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 180:2335-2340.
9. Moss, P.A., S.L. Rowland-Jones, P.M. Frodsham, S. McAdam, P. Giangrande, A.J. McMichael, and J.T. Bell. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci USA. 92:5773-5777.
10. + lymphocyte counts: immunologic and virologic characteristics. J. Infect. Dis. 163:959-965.
11. Johnson, R.P., A. Trocha, T.M. Buchanan, and B.D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961-971.
12. Walker, B.D., S. Chakrabarti, B. Moss, T.J. Paradis, T. Flynn, A.G. Durno, R.S. Blumberg J.C. Kaplan, M.S. Hirsch, and R.T. Schoolcy. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (Lond.). 328:345-348.
13. Walker, B.D., C. Flexner, T.J. Paradis, T.C. Fuller, M.S. Hirsch, R.T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science (Wash. DC). 240:64-66.
14. Walker, B.D. 1990. HIV-1-specific cytotoxic T lymphocytes. In Techniques in HIV Research. A. Aldovini and B.D. Walker, editors. Stockton Press, New York. 201-209.
15. Koup, R.A., C.A. Pikora, K. Luzuriaga, D.B. Brettler, E.S. Day, G.P. Mazzara, and J.L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174:1593-1600.
16. Lefkovits, I., and H. Waldmann. 1979. Limiting dilution analysis. In Limiting Dilution Analysis of Cells of the Immune System. Cambridge University Press, Cambridge. 61-82.
17. De St. Groth, F. 1982. The evaluation of limiting dilution assays. [Review]. J. Immunol. Methods. 49:R11-23.
18. Finney, D.I. 1978. Assays based on quantal responses. In Statistical Method in Biological Assay. 3rd ed. Charles Griffen & Co. LTD., London. 371-403.
19. Akella, R., and R. Porter. 1993. Rapid isolation and sequencing of double-stranded plasmid DNA. Biotechniques. 14: 726-730.
20. Jassoy, C., R.P. Johnson, B.A. Navia, J. Worth, and B.D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
21. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
22. Padovan, E., G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, and A. Lanzavecchia. 1993. Expression of two T cell receptor alpha chains: dual receptor T cells. Science (Wash. DC). 262:422-424.
23. DiBrino, M., K.C. Parker, D.H. Margulies, J. Shiloach, R.V. Turner, W.E. Biddison, and J.E. Coligan. 1994. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. J. Biol. Chem. 269: 32426-32434.
24. Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn et al., 1995. Viral dynamics in human immunodeficiency virus type 1 infection [see comments]. Nature (Lond.). 373.117-122.
25. Bergmann, C.C., L. Tong, R., Cua, J. Sensintaffar, and S. Stohlman. 1994. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68: 5306-5310.
26. Del Val, M., H.J. Schlicht, T. Ruppert, M.J. Reddehase, and U.H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell. 66:1145-1153.
27. Eisenlohr, L.C., J.W. Yewdell, and J.R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-487.
28. Rowley, D.A., and R.M. Stach. 1993. A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178:835-840.
29. Stach, R M., and D.A. Rowley. 1993. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor β and suppresses cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178:841-852.
30. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells [see comments]. Nature (Lond.). 369:407-410.
31. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A Edwards et al., 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants [see comments]. Nature. (Lond.). 369:403-407.
32. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1359-1366.
33. Nowak, M.A., R.M. May, R.E. Phillips, S. Rowland-Jones, D.G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmurid, C.R. Bangham et al., 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections [see comments]. Nature (Lond.). 375:606-611.
34. Moss, P.A., W.M. Rosenberg, E. Zintzaras, and J.I. Bell. 1993. Characterization of the human T cell receptor alpha-chain repertoire and demonstration of a genetic influence on V alpha usage. Eur. J. Immunol. 23:1153-1159.